FILAMENT HEALTH ANNOUNCES THIRD QUARTER 2022 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS Post published:November 10, 2022 Post category:Press Release
atai Life Sciences Reports Third Quarter 2022 Financial Results and Business Update Post published:November 10, 2022 Post category:Press Release
Reunion Neuroscience Schedules Fiscal Second Quarter 2023 Conference Call for Monday, November 14, 2022, at 8:30 A.M. ET Post published:November 7, 2022 Post category:Press Release
MindMed to Host Earnings Call to Discuss Third Quarter 2022 Financial Results and Provide Business Update Post published:November 5, 2022 Post category:Press Release
COMPASS Pathways Announces Third Quarter 2022 Financial Results and Business Highlights Post published:November 4, 2022 Post category:Press Release
Lusaris Therapeutics Launches with $60 Million Series A Financing to Redefine the Treatment of Severe Neuropsychiatric and Neurological Disorders Post published:November 2, 2022 Post category:Press Release
atai Life Sciences to Participate in November Investor Events & Healthcare Conferences Post published:November 2, 2022 Post category:Press Release
PharmaTher Enters into Exclusive Option Agreement with Case Western Reserve University to Develop and Commercialize Ketamine for Rett Syndrome Post published:November 2, 2022 Post category:Press Release
Braxia Scientific Announces Voting Results from the Annual General and Special Meeting of Shareholders Post published:November 2, 2022 Post category:Press Release
Numinus Re-Launches “Psychedelic Therapy Frontiers” Podcast with additional hosts and topics Post published:November 1, 2022 Post category:Press Release